Nephrogen, Inc.
Nephrogen, Inc. is a biotech company based in Bethel, Maine, focused on developing AI-driven curative genomic medicines aimed at treating kidney and pancreatic diseases, conditions that impact one in five Americans. The company's innovative NeFIND™ platform employs artificial intelligence and high-throughput in vivo screening to create novel gene delivery vectors that are significantly more efficient and less immunogenic than existing options.
Founded by a team of experts from Stanford and Harvard, including CEO Demetri Maxim and Chief Medical Officer Dr. Vivek Bhalla, Nephrogen aims to address the delivery challenges of genomic medicines to improve the longevity and quality of life for millions affected by genetic kidney diseases. The company is committed to realizing a vision of curing all genetic kidney diseases by 2030.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
